UPDATED: Clinician FAQS and guidance on COVID-19 vaccine

The Clinician FAQS and guidance on COVID-19 vaccine for patient receiving SACT. Version 6.0. Updated 21st December 2021 is now available on the UKCB website here: https://www.ukchemotherapyboard.org/publications. 

This updated guidance version 6 changes:
•    FAQ 1 Clarification for hormonal agents
•    FAQ 8 updated to reflect reinforcing (booster) dose after 3 primary doses.
•    FAQ13a: Updated figure
•    FAQ 13 FAQ 13b Updated to reflect change in recommendation about optimal timing.
•    New FAQ 14 added to reflect need for a reinforcing (booster) dose after 3rd primary dose

Please share with your colleagues.

Have a Merry Christmas and Happy New Year

Netty Cracknell and Pinkie Chambers
Co-chairs of the UK Chemotherapy Board

Latest News

By BOPA on 16th April 2024

Abstract Submission for #BOPA2024 is NOW OPEN

Abstract Submission for the 27th Annual BOPA Conference in 2024 is now OPEN   Delegates are invited to present results of their clinical and technical work as a poster with…

Read article
By BOPA Research Subcommittee on 15th April 2024

Survey: Service Evaluation on Carboplatin Variation in UK

We invite members to complete this service evaluation to understand national variations in carboplatin dosing for adult patients receiving SACTs. We are looking at whether we can standardise carboplatin protocols…

Read article
By BOPA on 11th April 2024

My Research Webinar – April 2024

Thursday 25th April 2024 1-2pm BST   Register for the Session HERE: https://www.bopa.org.uk/webinarsignupform/   We would like to invite you to join our  ‘My Research’ sessions. These sessions are delivered…

Read article
By BOPA Committee on 10th April 2024

Independent UK Pharmacy Professional Leadership Advisory Board launched to strengthen collaboration

BOPA is proud to be part of the UK PPL Board and represent all Pharmacy Professionals and Cancer Pharmacy Professionals across the UK. For more information see the letter on…

Read article